October 24, 2016
While genotypes 1, 2 and 3 can be found in relatively high numbers all over the world, genotype 4 is found almost exclusively the Middle East, Egypt and Central Africa. Still, there are so many infected patients in that part of the globe that genotype 4 comprises nearly 20% of cases worldwide. For example, approximately 15% of Egyptians have hepatitis C, compared with a 2% infection rate globally.
Patients can be treated with the drug regimens ombitasvir/paritaprevir/ritonavir (Technivie), sofosbuvir/velpatasvir, elbasvir/grazoprevir or sofosbuvir/ledipasvir.
Credit: naruedom for iStock via Thinkstock.
Sony Salzman is a freelance journalist reporting on health care and medicine, who has won awards in both narrative writing and radio journalism. Follow Salzman on Twitter: @sonysalz.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|No Increased Risk of Liver Cancer After Hepatitis C Treatment With Direct-Acting Antivirals|
|This Week in HIV Research: Another Person Possibly Cured of HIV; and Long-Acting Rilpivirine Suppresses HIV in Rectal Tissue|
|This Week in HIV Research: HIV-Related Inflammation May Be Irreversible; and Genetically Engineered T-Cells Resist HIV|
|How Close Are We to a Cure for HIV? A Q&A With HIV Cure Scientific Superstars|
|Dolutegravir and the Central Nervous System: A Top HIV Clinical Development of 2016|